Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Conversion |
2025-02-04 5:31 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC 10% Owner |
71,439,297 | $0 | 7,024,758 (Direct) |
View |
| 2025-02-03 Conversion |
2025-02-04 4:37 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director |
2,903,040 | $0 | 343,490 (Indirect) |
View |
| 2024-12-09 Option Award |
2025-02-04 4:37 pm |
N/A 2033-03-08 |
Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director |
14,790 | $0 | 343,490 (Direct) |
View |
| 2025-02-03 Conversion |
2025-02-04 4:35 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director |
422,206 | $0 | 251,293 (Direct) |
View |
| 2024-11-26 Conversion |
2025-02-04 4:35 pm |
N/A 2026-12-15 |
Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director |
75,000 | $78,962 | 251,293 (Indirect) |
View |
| 2024-12-09 Option Award |
2025-02-04 4:35 pm |
N/A 2031-03-03 |
Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director |
178,402 | $0 | 251,293 (Direct) |
View |
Ownership |
2025-01-30 8:55 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC 10% Owner |
0 | $0 | 65,036,879 (Direct) |
View |
Ownership |
2025-01-30 4:42 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 37,588,634 (Indirect) |
View |
Ownership |
2025-01-30 4:38 pm |
N/A 2030-10-25 |
Maze Therapeutics Inc. | MAZE | SPIEGELMAN DANIEL K Director |
0 | $0 | 35,534 (Direct) |
View |
Ownership |
2025-01-30 4:37 pm |
N/A 2031-02-01 |
Maze Therapeutics Inc. | MAZE | Sohn Catherine A. Director |
0 | $0 | 35,534 (Direct) |
View |
Ownership |
2025-01-30 4:35 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | SCHELLER RICHARD H Director |
0 | $0 | 43,643 (Direct) |
View |
Ownership |
2025-01-30 4:34 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director |
0 | $0 | 2,630,618 (Direct) |
View |
Ownership |
2025-01-30 4:33 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Kathiresan Sekar Director |
0 | $0 | 133,553 (Direct) |
View |
Ownership |
2025-01-30 4:31 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director |
0 | $0 | 520,621 (Direct) |
View |
Ownership |
2025-01-30 4:27 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Brush James Director |
0 | $0 | 15,731,923 (Indirect) |
View |
Ownership |
2025-01-30 4:25 pm |
N/A 2031-02-01 |
Maze Therapeutics Inc. | MAZE | Andrews Nancy C Director |
0 | $0 | 35,534 (Direct) |
View |
Ownership |
2025-01-30 4:24 pm |
N/A 2034-07-17 |
Maze Therapeutics Inc. | MAZE | Courtney Phillips GC and Corp. Secretary |
0 | $0 | 139,403 (Direct) |
View |
Ownership |
2025-01-30 4:22 pm |
N/A 2032-10-26 |
Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO |
0 | $0 | 555,438 (Direct) |
View |
Ownership |
2025-01-30 4:21 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance |
0 | $0 | 123,874 (Direct) |
View |
Ownership |
2025-01-30 4:19 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO |
0 | $0 | 327,556 (Direct) |
View |
Ownership |
2025-01-30 4:17 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer |
0 | $0 | 1,881,803 (Direct) |
View |